{"id":162180,"date":"2026-07-23T09:52:45","date_gmt":"2026-07-23T09:52:45","guid":{"rendered":"https:\/\/pabau.com\/?p=162180"},"modified":"2026-08-18T12:43:19","modified_gmt":"2026-08-18T12:43:19","slug":"icd-10-code-d810","status":"publish","type":"post","link":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/","title":{"rendered":"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID) with reticular dysgenesis\",\"description\":\"ICD-10 Code D81.0 identifies severe combined immunodeficiency (SCID) with reticular dysgenesis. Covers billable status, FY2026 validity, coding notes, sibling codes, documentation requirements, and ICD-9-CM crosswalk for medical coders and immunology clinicians.\",\"url\":\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-d810\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-07-07\",\"dateModified\":\"2026-07-07\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key Takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key Takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>ICD-10 Code D81.0 identifies severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype, marked by absence of both lymphocytes and myeloid cells.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>D81.0 is a billable ICD-10-CM code, valid for HIPAA-covered transaction submission, and current under the FY2026 edition effective October 1, 2025.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Documentation must include immunophenotyping results, genetic or laboratory confirmation of myeloid cell absence, and the treating clinician&#8217;s clinical findings to support this specific code over sibling codes D81.1 or D81.9.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Practice management software like Pabau gives immunology and specialist practices the claims management and client record tools to support the structured documentation this code requires and reduce denial risk.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\"><strong>ICD-10 Code D81.0<\/strong> is a billable, specific code for severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype, marked by absence of both lymphocytes and myeloid cells. This guide covers billable status and FY2026 validity, documentation requirements, sibling code comparisons, and the ICD-9-CM crosswalk coders and immunology clinicians need to assign the code accurately.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Other combined immunodeficiency subtypes affect T-cells and B-cells alone. Reticular dysgenesis eliminates both lymphoid and myeloid lineages, leaving patients with virtually no functional immune system from birth. Getting the code right affects reimbursement as well as the clinical record.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"ICD-10 Revisions: Stay Updated or Fall Behind\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/bqAyb-BCA0w?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 id=\"h-icd-10-code-d81-0-billable-status-and-fy2026-validity\" class=\"wp-block-heading\">ICD-10 Code D81.0: Billable status and FY2026 validity<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">D81.0 is a billable, specific ICD-10-CM diagnosis code. It is valid for submission on HIPAA-covered transactions and has been so since October 1, 2015. The FY2026 edition, effective October 1, 2025, carries no descriptor changes or exclusion revisions. Coders can submit this code on insurance claims, Medicare, and Medicaid transactions without additional specificity qualifiers.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">D81.0<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Full descriptor<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Severe combined immunodeficiency [SCID] with reticular dysgenesis<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billable\/specific<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HIPAA submission<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Valid for HIPAA-covered transactions<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">ICD-10-CM edition<\/td>\n<td style=\"padding:12px 16px;color:#374151\">FY2026 (effective October 1, 2025)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Original effective date<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2015<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Parent code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">D81 (Combined immunodeficiencies)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Chapter<\/td>\n<td style=\"padding:12px 16px;color:#374151\">D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">According to the <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/icd-10-codes\" target=\"_blank\" rel=\"nofollow noopener\">CMS ICD-10 codes page<\/a>, FY2026 update files confirm D81.0 carries no revisions from FY2025. Coders using the <a href=\"https:\/\/icd10cmtool.cdc.gov\/\" target=\"_blank\" rel=\"nofollow noopener\">CDC\/NCHS ICD-10-CM web tool<\/a> can verify current code validity and tabular notes directly against the official release. Pabau&#8217;s diagnostic-codes library covers other conditions coders look up alongside SCID.<\/p>\n\n\n\n<h2 id=\"h-clinical-description-what-is-scid-with-reticular-dysgenesis\" class=\"wp-block-heading\">Clinical description: What is SCID with reticular dysgenesis?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Severe combined immunodeficiency (SCID) is a group of rare, inherited primary immunodeficiency disorders in which both T-cell and B-cell immunity are profoundly impaired. D81.0 represents the most severe subtype: reticular dysgenesis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Where other SCID variants affect lymphoid cells selectively, reticular dysgenesis eliminates both lymphocytes (T-cells and B-cells) and myeloid cells, including neutrophils. The result is a near-complete collapse of both adaptive and innate immunity from birth.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Affected infants present within weeks of life with recurrent, severe infections from bacteria, viruses, and fungi that a functional immune system would routinely neutralize.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reticular dysgenesis is inherited as an autosomal recessive condition. Clinical literature links the condition to mutations in the AK2 gene, which encodes adenylate kinase 2, an enzyme critical to mitochondrial function in hematopoietic progenitor cells.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Molecular confirmation of the genetic basis is not always available at the time of initial coding. Documentation of the clinical phenotype, meaning absent myeloid and lymphoid populations on immunophenotyping, is sufficient to support D81.0 assignment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Clinically, reticular dysgenesis resembles other forms of SCID but is distinguished by the additional absence of granulocytes. Bone marrow examination typically shows a block at the earliest stages of hematopoiesis. Hematopoietic stem cell transplantation (HSCT) is the standard treatment, and outcomes depend heavily on early diagnosis and transplant timing.<\/p>\n\n\n\n<h2 id=\"h-d81-combined-immunodeficiency-icd-10-code-group-overview\" class=\"wp-block-heading\">D81 combined immunodeficiency ICD-10 code group overview<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">D81 is the parent category for combined immunodeficiencies in ICD-10-CM. Its subdivisions add up to 17 billable codes, alongside four non-billable parent codes, including D81 itself, that require a more specific fifth- or sixth-character code before submission.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Coders should select the most specific subcode supported by clinical documentation rather than defaulting to D81.9 (unspecified). The table below shows the billable D81.x codes.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Billable<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">SCID with reticular dysgenesis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">SCID with low T- and B-cell numbers<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.2<\/td>\n<td style=\"padding:12px 16px;color:#374151\">SCID with low or normal B-cell numbers<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.30<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Adenosine deaminase deficiency, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.31<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Severe combined immunodeficiency due to adenosine deaminase deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.32<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Adenosine deaminase 2 deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.39<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Other adenosine deaminase deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.4<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Nezelof&#8217;s syndrome<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.5<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Purine nucleoside phosphorylase [PNP] deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.6<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Major histocompatibility complex class I deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.7<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Major histocompatibility complex class II deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.810<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Biotinidase deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.818<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Other biotin-dependent carboxylase deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.819<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Biotin-dependent carboxylase deficiency, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.82<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.89<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Other combined immunodeficiencies<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Combined immunodeficiency, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">D81.81&#8217;s biotin-dependent carboxylase deficiencies are metabolic disorders rather than primary immune defects. They&#8217;re coded within the immunodeficiency chapter because untreated biotinidase deficiency also causes secondary immune dysfunction. Practices managing overlapping metabolic and immune presentations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Practices coding immunodeficiency disorders benefit from a clinical records system that flags incomplete workup data before a claim is submitted. Pabau&#8217;s client record tools give specialist practices structured templates to capture the immunophenotyping results and laboratory values that distinguish D81.0 from other D81.x codes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&#8217;s diagnostic-codes hub also covers related conditions coders reference alongside immunodeficiency.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-d810\/detailed-client-records-in-pabau.webp\" alt=\"Detailed client records in Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Detailed client records in Pabau<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Blood and immune diagnoses rest on lab results, and <a href=\"https:\/\/pabau.com\/features\/medical-lab-software\/\">medical lab software<\/a> moves orders and results without re-entry.<\/p>\n\n\n\n<h2 id=\"h-d81-0-coding-notes-applicable-to-excludes-and-hierarchy\" class=\"wp-block-heading\">D81.0 coding notes: Applicable-to, excludes, and hierarchy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-10-CM tabular list includes several hierarchy and notation rules for D81.0. Coders must apply these before finalizing a claim submission.<\/p>\n\n\n\n<h3 id=\"h-parent-hierarchy\" class=\"wp-block-heading\">Parent hierarchy<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">D81.0 sits within the following hierarchical path:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism<\/li>\n\n\n\n<li>D80-D89: Certain disorders involving the immune mechanism<\/li>\n\n\n\n<li>D81: Combined immunodeficiencies (parent, non-billable)<\/li>\n\n\n\n<li>D81.0: SCID with reticular dysgenesis (billable\/specific)<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-excludes-notes-for-d81\" class=\"wp-block-heading\">Excludes notes for D81<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The D81 parent category carries an Excludes 1 note. Excludes 1 means the excluded conditions cannot be coded at the same encounter as D81.0 because they are mutually exclusive diagnoses.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Excludes 1:<\/strong> Autosomal recessive agammaglobulinemia (Swiss type) (D80.0)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">There are no Excludes 2 notes specific to D81.0. Other primary immunodeficiency codes in the D80 and D83 ranges should not be assigned alongside D81.0 when a single, specific combined immunodeficiency diagnosis is supported by the clinical evidence.<\/p>\n\n\n\n<h3 id=\"h-applicable-to-notes\" class=\"wp-block-heading\">Applicable-to notes<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-10-CM tabular does not include a specific Applicable To note at the D81.0 level. The Applicable To notation appears at the D81 parent level and confirms the code block covers combined immunodeficiencies as a whole. Reticular dysgenesis is specifically named in the D81.0 descriptor and does not require an additional Applicable To qualifier.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>When documentation references &#8216;SCID&#8217; without specifying the subtype, do not default to D81.0. Query the ordering clinician for immunophenotyping results. If T-cell and B-cell counts are low but myeloid cells are preserved, D81.1 (SCID with low T- and B-cell numbers) is the correct code. D81.0 requires documented myeloid cell absence.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-diagnostic-criteria-and-documentation-for-reticular-dysgenesis-icd-10-coding\" class=\"wp-block-heading\">Diagnostic criteria and documentation for reticular dysgenesis ICD-10 coding<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Selecting ICD-10 Code D81.0 requires specific clinical evidence in the medical record. Immunologists and pediatricians managing SCID patients need documentation that supports the reticular dysgenesis subtype specifically, not just SCID in general.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The same documentation discipline applies across other specialties working up rare, multi-system presentations. Missing documentation is the main reason claims for rare immunodeficiency codes face additional review.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The following elements should appear in the medical record before D81.0 is assigned:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immunophenotyping results:<\/strong> Lab report showing absent or severely reduced T-lymphocytes, B-lymphocytes, and natural killer (NK) cells<\/li>\n\n\n\n<li><strong>Myeloid cell assessment:<\/strong> CBC with differential or bone marrow biopsy showing absence of neutrophils and other myeloid lineage cells<\/li>\n\n\n\n<li><strong>Clinical presentation:<\/strong> Documentation of recurrent severe infections presenting within weeks to months of birth<\/li>\n\n\n\n<li><strong>Genetic or molecular testing (if available):<\/strong> AK2 gene mutation confirmation strengthens specificity, though it is not required to assign D81.0 when the clinical and laboratory phenotype supports reticular dysgenesis<\/li>\n\n\n\n<li><strong>Attending clinician&#8217;s narrative:<\/strong> The treating physician must explicitly document the diagnosis of SCID with reticular dysgenesis, not merely \u00abcombined immunodeficiency\u00bb<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Practices that maintain structured electronic health records reduce the time spent locating these elements at audit. Pabau&#8217;s digital intake tools allow immunology practices to build condition-specific documentation workflows that capture immunophenotyping results, laboratory values, and clinical narrative in one place.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For broader guidance on HIPAA-compliant documentation practices.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-d810\/customizable-consent-and-intake-forms.webp\" alt=\"Customizable consent and intake forms\"\/><figcaption class=\"wp-element-caption\"><em>Customizable consent and intake forms<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Clinical documentation that holds up at audit                <\/h3>\n\n                <p class=\"description\">\n                    Pabau gives specialty practices structured digital forms, comprehensive client records, and automated workflows so the clinical evidence supporting ICD-10 Code D81.0 and other rare diagnosis codes is captured at the point of care, not chased after submission.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau clinical documentation for immunology practices\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 id=\"h-d81-0-vs-related-immunodeficiency-codes\" class=\"wp-block-heading\">D81.0 vs. related immunodeficiency codes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Other ICD-10-CM categories besides D81 also cover immunodeficiency. Coders working with patients who present broad immunodeficiency symptoms need to distinguish D81.0 from similar codes in adjacent categories.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Selecting the wrong code misrepresents the patient&#8217;s condition, and in audits, can flag a pattern of non-specific coding. The <a href=\"https:\/\/www.aapc.com\/codes\/icd-10-codes-range\/\" target=\"_blank\" rel=\"nofollow noopener\">AAPC ICD-10-CM code lookup<\/a> and the <a href=\"https:\/\/icd.who.int\/browse10\/2019\/en\" target=\"_blank\" rel=\"nofollow noopener\">WHO ICD-10 browser<\/a> both provide navigable hierarchies for cross-checking code selection.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Key distinction from D81.0<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">SCID with reticular dysgenesis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Absent lymphocytes AND myeloid cells (most severe subtype)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">SCID with low T- and B-cell numbers<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Myeloid cells preserved; lymphopenia documented<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.2<\/td>\n<td style=\"padding:12px 16px;color:#374151\">SCID with low or normal B-cell numbers<\/td>\n<td style=\"padding:12px 16px;color:#374151\">T-cell deficiency primary; B-cells may be present<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Combined immunodeficiency, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Use only when subtype is clinically undetermined<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D80.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Hereditary hypogammaglobulinemia<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Antibody deficiency only; T-cell function intact<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D83.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Common variable immunodeficiency, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Acquired; typically presents in adolescence or adulthood<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The clearest differentiator for D81.0 is myeloid cell absence. No other D81 subcode requires documented absence of granulocytes. If the patient&#8217;s CBC shows normal neutrophil counts, D81.0 is not supportable regardless of the severity of lymphopenia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Coders working with pediatric immunology records should also confirm whether the ordering clinician distinguished between SCID and combined immunodeficiency secondary to an acquired condition, such as HIV, which falls under a different ICD-10-CM chapter entirely.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&#8217;s diagnostic-codes library also covers pediatric-adjacent conditions coders reference alongside SCID.<\/p>\n\n\n\n<h2 id=\"h-code-history-and-annual-updates-for-d81-0\" class=\"wp-block-heading\">Code history and annual updates for D81.0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">D81.0 has been active since the initial ICD-10-CM implementation in the United States. The code has remained stable across all fiscal year editions without descriptor revisions, billable status changes, or hierarchical restructuring.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to <a href=\"https:\/\/resdac.org\/articles\/international-classification-disease-icd-codes-medicare-files\" target=\"_blank\" rel=\"nofollow noopener\">ResDAC ICD code guidance<\/a>, practices should verify code validity annually against the CMS update release, typically published in the summer preceding the October 1 effective date.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Fiscal year<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Effective date<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Status<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Changes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">FY2016<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2015<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Active<\/td>\n<td style=\"padding:12px 16px;color:#374151\">New code (ICD-10-CM implementation)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">FY2017-FY2024<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2016-2023<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Active<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No changes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">FY2025<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2024<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Active<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No changes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">FY2026<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2025<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Active<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No changes; descriptor unchanged<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Coders at practices that submit claims for SCID diagnoses should confirm each fiscal year&#8217;s validity table before the annual October 1 transition. Specialty practices using EHR systems should also review how their documentation workflow handles annual code set updates.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&#8217;s direct primary care EHR guide covers how practice management platforms manage code set transitions and annual update rollouts.<\/p>\n\n\n\n<h2 id=\"h-icd-9-cm-crosswalk-for-d81-0\" class=\"wp-block-heading\">ICD-9-CM crosswalk for D81.0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Practices managing legacy claims or reviewing historical records may need the ICD-9-CM equivalent for SCID with reticular dysgenesis. The General Equivalence Mapping (GEM) files published by CMS and NCHS provide the official crosswalk between ICD-9-CM and ICD-10-CM. Practices handling historical billing records should verify crosswalk accuracy through the official CMS GEM files rather than relying on commercial tools alone.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10-CM Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-9-CM Equivalent<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description (ICD-9-CM)<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">GEM mapping type<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D81.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">279.2<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Combined immunity deficiency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Approximate (ICD-9-CM had no reticular dysgenesis-specific code)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-9-CM system did not have a code specific to reticular dysgenesis. Code 279.2 (combined immunity deficiency) served as the closest equivalent, but it covered the entire combined immunodeficiency spectrum without subtype differentiation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The transition to ICD-10-CM in October 2015 introduced the granular D81.x coding structure that lets reticular dysgenesis be distinguished from other combined immunodeficiency subtypes. Practices reviewing historical crosswalk data can refer to Pabau&#8217;s HIPAA compliance guide for how EHR systems handle legacy claim records.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>When converting pre-2015 records, note that ICD-9 code 279.2 maps to multiple ICD-10-CM codes in the D81 group, not exclusively to D81.0. Always review the contemporaneous clinical record to determine whether the ICD-10-CM subcode is supportable, rather than defaulting to the approximate GEM crosswalk.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Related ICD-10 codes<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-d329-meningioma-unspecified\/\">ICD-10 code D32.9 \u2014 Benign Neoplasm of Meninges, Unspecified<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-d849\/\">ICD-10 code D84.9 \u2014 Immunodeficiency, unspecified<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-d061\/\">ICD-10 code D06.1 \u2014 Carcinoma in situ of exocervix<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-d100\/\">ICD-10 code D10.0 \u2014 Benign neoplasm of lip<\/a><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">SCID with reticular dysgenesis is the rarest, most severe form of combined immunodeficiency in the ICD-10-CM classification. Assigning D81.0 correctly requires documented myeloid cell absence alongside the standard lymphopenia criteria, a distinction that separates this code from every other sibling in the D81 group. The code is billable, HIPAA-valid, and unchanged for FY2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Immunology and pediatric specialty practices that capture structured laboratory and clinical narrative data at the point of care run into far fewer documentation shortfalls at claim submission. Pabau&#8217;s clinical EMR tools are built for practices where diagnostic specificity directly determines reimbursement outcomes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To see how Pabau supports specialty documentation workflows, <a href=\"https:\/\/pabau.com\/book-demo\/\">book a demo<\/a> with the team.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Coding acute infections in immunocompromised patients?<\/strong> ICD-10 Code <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-j22\/\">J22<\/a> covers documentation and billing for unspecified acute lower respiratory infection.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need a reference for another rare, congenital diagnosis?<\/strong> ICD-10 Code <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-q200\/\">Q20.0<\/a> covers billable status and documentation for common truncus.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing for point-of-care lab testing during a workup?<\/strong> HCPCS Code <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-a4252\/\">A4252<\/a> covers reagent strip billing rules for blood ketone testing.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-frequently-asked-questions\" class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1784794358756\"><h3 class=\"schema-faq-question\">What is ICD-10 Code D81.0 used for?<\/h3> <p class=\"schema-faq-answer\">ICD-10 Code D81.0 is used to document and bill for severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype. It is assigned when clinical and laboratory findings confirm absence of both lymphocytes and myeloid cells. The code applies in pediatric immunology, inpatient, and outpatient settings where the diagnosis has been established by an immunologist or treating physician.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784794358757\"><h3 class=\"schema-faq-question\">Is D81.0 a billable ICD-10-CM code?<\/h3> <p class=\"schema-faq-answer\">Yes, D81.0 is a billable, specific ICD-10-CM code valid for HIPAA-covered transaction submission. It has been billable since October 1, 2015, and remains active and unchanged under the FY2026 edition effective October 1, 2025.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784794358758\"><h3 class=\"schema-faq-question\">What is the ICD-10 code for SCID without specifying the subtype?<\/h3> <p class=\"schema-faq-answer\">D81.9 (combined immunodeficiency, unspecified) is the correct code when the SCID subtype has not been clinically determined. Coders should use D81.9 only when the medical record does not support selection of a more specific code such as D81.0, D81.1, or D81.2. Querying the ordering clinician for immunophenotyping results before defaulting to unspecified is standard coding practice.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784794358759\"><h3 class=\"schema-faq-question\">What is reticular dysgenesis and how does it differ from other SCID forms?<\/h3> <p class=\"schema-faq-answer\">Reticular dysgenesis is a form of SCID in which both lymphoid cells (T-cells and B-cells) and myeloid cells (neutrophils and other granulocytes) are absent from birth. Other SCID forms affect only the lymphoid lineage. This dual lineage failure makes reticular dysgenesis the most severe primary immunodeficiency and the only SCID subtype that also presents with agranulocytosis. This distinction is what separates D81.0 from all other D81.x codes at the coding level.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784794358760\"><h3 class=\"schema-faq-question\">When did ICD-10-CM D81.0 become effective, and is it valid for 2026?<\/h3> <p class=\"schema-faq-answer\">D81.0 became effective October 1, 2015, when ICD-10-CM replaced ICD-9-CM in the United States. The FY2026 edition (effective October 1, 2025) confirms D81.0 remains active with no descriptor or exclusion revisions. It is valid for all HIPAA-covered transactions submitted on or after October 1, 2025.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784794358761\"><h3 class=\"schema-faq-question\">What are the excludes notes for D81.0?<\/h3> <p class=\"schema-faq-answer\">The Excludes 1 note at the D81 parent level prohibits coding autosomal recessive agammaglobulinemia (Swiss type) (D80.0) at the same encounter as any D81.x code, including D81.0. Excludes 1 means the two conditions cannot coexist under the same code category. There are no Excludes 2 notes specific to D81.0 itself.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>ICD-10 Code D81.0 is a billable, specific code for severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype, marked by absence of both lymphocytes and myeloid cells. This guide covers billable status and FY2026 validity, documentation requirements, sibling code comparisons, and the ICD-9-CM crosswalk coders and immunology clinicians need to [&hellip;]<\/p>\n","protected":false},"author":77,"featured_media":162178,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"88","_yoast_wpseo_content_score":"30","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1549,1550],"tags":[],"class_list":["post-162180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diagnostic-codes","category-icd-10-cm"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)<\/title>\n<meta name=\"description\" content=\"D81.0 is a billable ICD-10-CM code for SCID with reticular dysgenesis, requiring documented absence of both lymphocytes and myeloid cells.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)\" \/>\n<meta property=\"og:description\" content=\"D81.0 is a billable ICD-10-CM code for SCID with reticular dysgenesis, requiring documented absence of both lymphocytes and myeloid cells.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-23T09:52:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-18T12:43:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-d810.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Katy Piper\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katy Piper\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/\"},\"author\":{\"name\":\"Katy Piper\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\"},\"headline\":\"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)\",\"datePublished\":\"2026-07-23T09:52:45+00:00\",\"dateModified\":\"2026-08-18T12:43:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/\"},\"wordCount\":2300,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-d810.webp\",\"articleSection\":[\"Diagnostic Codes\",\"ICD-10-CM\"],\"inLanguage\":\"es\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/\",\"name\":\"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-d810.webp\",\"datePublished\":\"2026-07-23T09:52:45+00:00\",\"dateModified\":\"2026-08-18T12:43:19+00:00\",\"description\":\"D81.0 is a billable ICD-10-CM code for SCID with reticular dysgenesis, requiring documented absence of both lymphocytes and myeloid cells.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358756\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358757\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358758\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358759\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358760\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358761\"}],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-d810.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-d810.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\",\"name\":\"Katy Piper\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"caption\":\"Katy Piper\"},\"description\":\"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/blog\\\/author\\\/katy-piper\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358756\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358756\",\"name\":\"What is ICD-10 Code D81.0 used for?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ICD-10 Code D81.0 is used to document and bill for severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype. It is assigned when clinical and laboratory findings confirm absence of both lymphocytes and myeloid cells. The code applies in pediatric immunology, inpatient, and outpatient settings where the diagnosis has been established by an immunologist or treating physician.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358757\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358757\",\"name\":\"Is D81.0 a billable ICD-10-CM code?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, D81.0 is a billable, specific ICD-10-CM code valid for HIPAA-covered transaction submission. It has been billable since October 1, 2015, and remains active and unchanged under the FY2026 edition effective October 1, 2025.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358758\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358758\",\"name\":\"What is the ICD-10 code for SCID without specifying the subtype?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"D81.9 (combined immunodeficiency, unspecified) is the correct code when the SCID subtype has not been clinically determined. Coders should use D81.9 only when the medical record does not support selection of a more specific code such as D81.0, D81.1, or D81.2. Querying the ordering clinician for immunophenotyping results before defaulting to unspecified is standard coding practice.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358759\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358759\",\"name\":\"What is reticular dysgenesis and how does it differ from other SCID forms?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Reticular dysgenesis is a form of SCID in which both lymphoid cells (T-cells and B-cells) and myeloid cells (neutrophils and other granulocytes) are absent from birth. Other SCID forms affect only the lymphoid lineage. This dual lineage failure makes reticular dysgenesis the most severe primary immunodeficiency and the only SCID subtype that also presents with agranulocytosis. This distinction is what separates D81.0 from all other D81.x codes at the coding level.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358760\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358760\",\"name\":\"When did ICD-10-CM D81.0 become effective, and is it valid for 2026?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"D81.0 became effective October 1, 2015, when ICD-10-CM replaced ICD-9-CM in the United States. The FY2026 edition (effective October 1, 2025) confirms D81.0 remains active with no descriptor or exclusion revisions. It is valid for all HIPAA-covered transactions submitted on or after October 1, 2025.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358761\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/diagnostic-codes\\\/icd-10-code-d810\\\/#faq-question-1784794358761\",\"name\":\"What are the excludes notes for D81.0?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Excludes 1 note at the D81 parent level prohibits coding autosomal recessive agammaglobulinemia (Swiss type) (D80.0) at the same encounter as any D81.x code, including D81.0. Excludes 1 means the two conditions cannot coexist under the same code category. There are no Excludes 2 notes specific to D81.0 itself.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)","description":"D81.0 is a billable ICD-10-CM code for SCID with reticular dysgenesis, requiring documented absence of both lymphocytes and myeloid cells.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/","og_locale":"es_ES","og_type":"article","og_title":"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)","og_description":"D81.0 is a billable ICD-10-CM code for SCID with reticular dysgenesis, requiring documented absence of both lymphocytes and myeloid cells.","og_url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-07-23T09:52:45+00:00","article_modified_time":"2026-08-18T12:43:19+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-d810.webp","type":"image\/webp"}],"author":"Katy Piper","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"Escrito por":"Katy Piper","Tiempo de lectura":"11 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/"},"author":{"name":"Katy Piper","@id":"https:\/\/pabau.com\/es\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d"},"headline":"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)","datePublished":"2026-07-23T09:52:45+00:00","dateModified":"2026-08-18T12:43:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/"},"wordCount":2300,"publisher":{"@id":"https:\/\/pabau.com\/es\/#organization"},"image":{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-d810.webp","articleSection":["Diagnostic Codes","ICD-10-CM"],"inLanguage":"es"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/","url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/","name":"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)","isPartOf":{"@id":"https:\/\/pabau.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-d810.webp","datePublished":"2026-07-23T09:52:45+00:00","dateModified":"2026-08-18T12:43:19+00:00","description":"D81.0 is a billable ICD-10-CM code for SCID with reticular dysgenesis, requiring documented absence of both lymphocytes and myeloid cells.","mainEntity":[{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358756"},{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358757"},{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358758"},{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358759"},{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358760"},{"@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358761"}],"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-d810.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-d810.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/es\/#website","url":"https:\/\/pabau.com\/es\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/pabau.com\/es\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pabau.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/es\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d","name":"Katy Piper","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","caption":"Katy Piper"},"description":"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.","url":"https:\/\/pabau.com\/es\/blog\/author\/katy-piper\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358756","position":1,"url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358756","name":"What is ICD-10 Code D81.0 used for?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"ICD-10 Code D81.0 is used to document and bill for severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype. It is assigned when clinical and laboratory findings confirm absence of both lymphocytes and myeloid cells. The code applies in pediatric immunology, inpatient, and outpatient settings where the diagnosis has been established by an immunologist or treating physician.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358757","position":2,"url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358757","name":"Is D81.0 a billable ICD-10-CM code?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes, D81.0 is a billable, specific ICD-10-CM code valid for HIPAA-covered transaction submission. It has been billable since October 1, 2015, and remains active and unchanged under the FY2026 edition effective October 1, 2025.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358758","position":3,"url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358758","name":"What is the ICD-10 code for SCID without specifying the subtype?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"D81.9 (combined immunodeficiency, unspecified) is the correct code when the SCID subtype has not been clinically determined. Coders should use D81.9 only when the medical record does not support selection of a more specific code such as D81.0, D81.1, or D81.2. Querying the ordering clinician for immunophenotyping results before defaulting to unspecified is standard coding practice.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358759","position":4,"url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358759","name":"What is reticular dysgenesis and how does it differ from other SCID forms?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Reticular dysgenesis is a form of SCID in which both lymphoid cells (T-cells and B-cells) and myeloid cells (neutrophils and other granulocytes) are absent from birth. Other SCID forms affect only the lymphoid lineage. This dual lineage failure makes reticular dysgenesis the most severe primary immunodeficiency and the only SCID subtype that also presents with agranulocytosis. This distinction is what separates D81.0 from all other D81.x codes at the coding level.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358760","position":5,"url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358760","name":"When did ICD-10-CM D81.0 become effective, and is it valid for 2026?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"D81.0 became effective October 1, 2015, when ICD-10-CM replaced ICD-9-CM in the United States. The FY2026 edition (effective October 1, 2025) confirms D81.0 remains active with no descriptor or exclusion revisions. It is valid for all HIPAA-covered transactions submitted on or after October 1, 2025.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358761","position":6,"url":"https:\/\/pabau.com\/es\/diagnostic-codes\/icd-10-code-d810\/#faq-question-1784794358761","name":"What are the excludes notes for D81.0?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The Excludes 1 note at the D81 parent level prohibits coding autosomal recessive agammaglobulinemia (Swiss type) (D80.0) at the same encounter as any D81.x code, including D81.0. Excludes 1 means the two conditions cannot coexist under the same code category. There are no Excludes 2 notes specific to D81.0 itself.","inLanguage":"es"},"inLanguage":"es"}]}},"yoast":{"focus_keyword":"ICD-10 Code D81.0","seo_title":"ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)","meta_description":"D81.0 is a billable ICD-10-CM code for SCID with reticular dysgenesis, requiring documented absence of both lymphocytes and myeloid cells.","content_score":"30","is_cornerstone":"","related_keyphrases":[{"keyword":"combined immunodeficiency ICD-10","score":81},{"keyword":"reticular dysgenesis diagnosis code","score":61},{"keyword":"primary immunodeficiency ICD-10","score":61}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts\/162180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/comments?post=162180"}],"version-history":[{"count":5,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts\/162180\/revisions"}],"predecessor-version":[{"id":184050,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts\/162180\/revisions\/184050"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/media\/162178"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/media?parent=162180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/categories?post=162180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/tags?post=162180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}